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The COVID-19 pandemic is likely an epic reshaping of
human behavior across the globe. Beyond our knowledge of previous pandemics and infections, COVID19 demanded extraordinary changes in our lifestyle.
The virus spread rapidly across the globe due to its
high transmissibility, and the extraordinary death toll
was unprecedented. In the early stages of this pandemic, there was a sense of powerlessness leading us
to isolation from public gathering. Under the leadership of the World Health Organization (WHO), the
Centers for Disease Control and Prevention (CDC), and
other organizations, the predominant response was to
use preventive measures, including social distancing,
hand washing and face masks. These measures have
been very effective in preventing infection and containing the spread of infection in previous epidemics and
pandemics. Ongoing protective measures are critical to
mitigate the pandemic; however, controversies persist
concerning the use of face masks as a protection measure against COVID.
One of the greatest privileges of today’s world is the
right to have our own opinion on any finding and
to share it through digital media. Diversity of opinion makes our world rich with ideas; however, some
opinions—well-intentioned or otherwise—can result in
suffering and loss of lives.
Constructive scientists recognize the limitations of our
knowledge and develop hypotheses in efforts to expand it. Unfortunately, in the time of the infodemic,
not all medical research—particularly articles posted
as preprints—undergo rigorous scientific scrutiny. Our
journal previously published our position on preprints
as potentially unreliable sources of knowledge.[1] Furthermore, traditional and social media are being used
to spread misinformation and disinformation despite
the efforts of infodemic surveillance organizations. In
this note, we would like to address the controversy reULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/27

garding whether the use of face masks by people in the
community prevents infection and the spread of infection to others.
The CDC recommends the use of a face mask consisting
of two or more layers of fabric for those not fully vaccinated or who have a weak immune system; masks
are universally recommended (regardless of vaccination or immune status) in indoor public places and in
public transportation to mitigate the spread of the Delta
variant of SARS-CoV-2. For these purposes, the U.S.
Food & Drug Administration defines a face mask as
“a mask, with or without a face shield, that covers the
user’s nose and mouth and may or may not meet fluid
barrier or filtration efficiency levels”.[2] In the case of
non-medical face masks, filtration efficacy is variable.
An important point for clarification is the mask filtration efficiency for particles including the SARS-CoV-2
virus. Typically, the virus is transmitted through the air
by droplets—particles greater than 5 µm in diameter—
however, it can also be transmitted in smaller particles
(<1 µm). Filtration efficiency is the percentage of particles blocked by the mask. As a reference, medical
masks are certified by the American Society for Testing
and Material (ASTM) International with an efficiency
≥95% (Level 1) or ≥98% (Levels 2 and 3) for particles
0.1 µm in diameter.[3]

What does the current literature tell us?
Filtration efficiency
Van der Sande et al. reported the inward filtration efficiency for a 1-layer tea towel at 55–77% and outward at
17% for 0.02–1 µm particles.[4] The low outward efficiency could be explained by the 1-layer composition
and the fact that particles are expelled from the upper respiratory tract and mouth, which are high pres1
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sure spaces. Dato et al. reported an efficiency >90%
for multilayer homemade masks. Overall, if we follow
the CDC recommendation to use a ≥2-layer fabric face
mask, substantial protection is expected for the user, as
well as substantial mitigation of viral spread.[5]
Effectiveness of mask use
The effectiveness of face mask use against past and
present pandemics is well-attested in the literature. The
following is a summary of the findings of five systematic reviews and meta-analyses on the subject.
In 2020, few studies of mask use against COVID-19 had
been published; evidence primarily consisted of studies concerning other coronaviruses and other respiratory pathogens. In June 2020, Chu et al. found that
across six studies, persons wearing face masks were
at one-third the risk of infection from SARS-CoV and
MERS-CoV, Betacoronaviruses similar to SARS-CoV2, compared to those with uncovered faces (adjusted
odds ratio [OR] 0.33, 95% confidence interval [CI] 0.17–
0.61, I2 =76%).[6] Liang et al. (July 2020) similarly found
that across 21 studies, including one on SARS-CoV-2,
face mask users were at 35% the risk of infection from
respiratory viruses compared to those with uncovered
faces (pooled OR 0.35, 95% CI 0.24–0.51, I2 =60%).[7]
In subgroup analyses, the OR [95% CI] for healthcare
workers across 12 studies was 0.20 [0.11–0.37] and for
non-healthcare workers across eight studies was 0.53
[0.36–0.79].
By 2021, richer literature on mask use against SARSCoV-2 specifically was available for meta-analysis. In
January 2021, Tabatabaeizadeh et al. demonstrated a
significant reduction in SARS-CoV-2 infection risk with
face mask use across four studies (pooled relative risk
[RR] 0.12, 95% CI: 0.06–0.27, P<0.001).[8] In a metaanalysis by Hemmer et al. (February 2021) of 29 studies on SARS-CoV, MERS-CoV, and SARS-CoV-2, mask
use was associated with one-third odds of infection
(adjusted OR 0.04, 95% CI: 0.004–0.3 [N95 respirators]
and 0.33, 95% CI 0.17–0.61 [other masks]).[9] Li et al.
(July 2021) similarly found that across six studies, wearing a mask was associated with significantly reduced
odds of COVID-19 infection (OR 0.38, 95% CI: 0.21–
0.69, I2 =54.1%).[10]
Effectiveness of government-mandated mask use
A 2021 cross-sectional study found that a 10% increase
in self-reported mask use was associated with a more
than three-fold increase in odds of transmission control
(multivariate logistic regression model with 10-point
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extrapolation, adjusting for confounders, physical distancing, and a time trend).[11] However, the study
also found no statistically significant change in average mask usage as a result of government mandate. By
contrast, MacIntyre et al. observed a statistically significant association between mask mandates and mask use
in univariate regression analysis (P<0.001).[12]
In a 2020 ecological study, Fang et al. found that counties in states with face mask mandates were at significantly less risk of COVID-19 incidence, with an adjusted risk ratio of 0.8462 (95% CI: 0.7592–0.9433).[13]
This association was observed during the second surge
(May 28–September 12, 2020), but not during the first
surge (up to May 28, 2020).
A study of SARS-CoV-2 spread prior to the start of
vaccination found that the rapid implementation of
mask mandates was associated with lower rates of infection.[14] States that implemented mask mandates
3–6 months after the start of their respective SARSCoV-2 epidemic (defined as ≥50 cases present in the
state) had an infection rate 1.61 times higher than
states that implemented a mask mandate within one
month (adjusted rate ratio 1.61 (95% CI: 1.23–2.10),
P<0.001). States that implemented mask mandates after six months or did not implement mask mandates
had an infection rate 2.16 times higher than states that
implemented a mask mandate within one month (adjusted rate ratio 2.16 (95% CI: 1.64–2.88, P<0.0001).

Conclusion
Despite the many medical resources at our disposal,
the landscape of the COVID-19 epidemic looks like a
disastrous battlefield in the US. As of August 25, 2021,
there have been 38,077,814 confirmed cases of COVID19 and 630,840 deaths, while only 51.6% of the US population is fully vaccinated.[15, 16] The most recent complete epidemiological week (August 15–21, 2021) saw
nearly a million new cases of COVID-19 reported to the
CDC, the greatest surge since 1.7 million were reported
at the beginning of 2021 (Figure 1). The surge is largely
among the unvaccinated and demands extraordinary
measures to contain it. Regardless of the relatively limited data and lack of optimal randomized controlled trials to confirm the benefit of face masks against COVID19, the available data indicate a moderate protection
that is crucial to protect our communities. We strongly
recommend the use of face masks to the public in line
with the recommendations of the CDC and the Infectious Diseases Society of America.
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Figure 1. Cases of COVID-19 reported to the Centers for Disease Control and Prevention (CDC) per week.

ULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/27

3

ULJRI

Acknowledgements: The authors would like to thank Jessica Petrey, MSLS, for conducting the literature search.

Why Should People Use Face Masks in the Time of COVID?

tion 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.

Published: August 25, 2021
Copyright: © 2021 The author(s). This original article is
brought to you for free and open access by ThinkIR: The University of Louisville’s Institutional Repository. For more information, please contact thinkir@louisville.edu. This article is
distributed under the terms of the Creative Commons Attribu-

Funding Source: The author(s) received no specific funding
for this work
Conflict of Interest: All authors declared no conflict of interest in relation to the main objective of this work.

References
1. Arnold F, Buckner K, Glynn A, Petrey J, Bordon J. To
Preprint or Not to Preprint. Univ Louisville J Respir Infect
2021; 5(1):Article 12. doi: 10.18297/jri/vol5/iss1/12.

9. Hemmer CJ, Hufert F, Siewert S, Reisinger E. Protection
From COVID-19. Dtsch Arztebl Int 2021; 118(5):59-65. doi:
10.3238/arztebl.m2021.0119. PMID: 33785117.

2. U.S. Food & Drug Administration. Face Masks, Including
Surgical Masks, and Respirators for COVID-19. Available at:
https://www.fda.gov/medical-devices/coronavirus-covid-19and-medical-devices/face-masks-including-surgical-masksand-respirators-covid-19. Accessed 25 August 2021.

10. Li Y, Liang M, Gao L, et al. Face masks to prevent
transmission of COVID-19: A systematic review and metaanalysis. Am J Infect Control 2021; 49(7):900-6. doi:
10.1016/j.ajic.2020.12.007. PMID: 33347937.

3. American Society for Testing and Materials. Understanding ASTM Levels for face masks.
Available at:
https://www.coronavirus.kdheks.gov/DocumentCenter/View/
1416/Understanding-ASTM-Levels-for-facemasks-PDF---730-20. Accessed 25 August 2021.
4. van der Sande M, Teunis P, Sabel R. Professional and
home-made face masks reduce exposure to respiratory infections among the general population. PLoS One 2008;
3(7):e2618. doi: 10.1371/journal.pone.0002618. PMID:
18612429.
5. Dato VM, Hostler D, Hahn ME. Simple respiratory
mask.
Emerg Infect Dis 2006; 12(6):1033-4.
doi:
10.3201/eid1206.051468. PMID: 16752475.
6. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann
HJ. Physical distancing, face masks, and eye protection
to prevent person-to-person transmission of SARS-CoV-2
and COVID-19: a systematic review and meta-analysis.
Lancet 2020; 395(10242):1973-87. doi: 10.1016/s01406736(20)31142-9. PMID: 32497510.

11. Rader B, White LF, Burns MR, et al. Mask-wearing and
control of SARS-CoV-2 transmission in the USA: a crosssectional study. Lancet Digit Health 2021; 3(3):e148-e57. doi:
10.1016/s2589-7500(20)30293-4. PMID: 33483277.
12. MacIntyre CR, Nguyen P-Y, Chughtai AA, et al. Mask
use, risk-mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia,
the UK and USA: A cross-sectional survey. International
Journal of Infectious Diseases 2021; 106:199-207. doi:
10.1016/j.ijid.2021.03.056.
13. Fang F, Mu L, Zhu Y, Rao J, Heymann J, Zhang
ZF. Long-Term Exposure to PM(2.5), face mask Mandates,
Stay Home Orders and COVID-19 Incidence in the United
States. Int J Environ Res Public Health 2021; 18(12). doi:
10.3390/ijerph18126274. PMID: 34200600.
14. Krishnamachari B, Morris A, Zastrow D, Dsida A, Harper
B, Santella AJ. The role of mask mandates, stay at home orders and school closure in curbing the COVID-19 pandemic
prior to vaccination. AJIC: American Journal of Infection Control 2021; 49(8):1036-42. doi: 10.1016/j.ajic.2021.02.002.

7. Liang M, Gao L, Cheng C, et al. Efficacy of face
mask in preventing respiratory virus transmission: A systematic review and meta-analysis. Travel Med Infect Dis
2020; 36:101751. doi: 10.1016/j.tmaid.2020.101751. PMID:
32473312.

15. Centers for Disease Control and Prevention. COVID19 Vaccinations in the United States. Available at: https:
//covid.cdc.gov/covid-data-tracker/#vaccinations vacc-totaladmin-rate-total. Accessed 25 August 2021.

8. Tabatabaeizadeh SA. Airborne transmission of COVID-19
and the role of face mask to prevent it: a systematic review and meta-analysis. Eur J Med Res 2021; 26(1):1. doi:
10.1186/s40001-020-00475-6. PMID: 33388089.

16. Center for Systems Science and Engineering at Johns
Hopkins University. COVID-19 Dashboard. Available at:
https://coronavirus.jhu.edu/map.html. Accessed 25 August
2021.

ULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/27

4

